| Year |
Citation |
Score |
| 2020 |
Glassman PM, Walsh LR, Villa CH, Marcos-Contreras OA, Hood ED, Muzykantov VR, Greineder CF. Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery. Bioconjugate Chemistry. PMID 32167754 DOI: 10.1021/Acs.Bioconjchem.0C00003 |
0.313 |
|
| 2018 |
Hood ED, Greineder CF, Shuvaeva T, Walsh L, Villa CH, Muzykantov VR. Vascular targeting of radiolabeled liposomes with bio-orthogonally conjugated ligands: single chain fragments provide higher specificity than antibodies. Bioconjugate Chemistry. PMID 30240185 DOI: 10.1021/Acs.Bioconjchem.8B00564 |
0.341 |
|
| 2017 |
Greineder CF, Villa CH, Walsh LR, Kiseleva RY, Hood ED, Khoshnejad M, Warden-Rothman R, Tsourkas A, Muzykantov VR. Site-specific modification of single-chain antibody fragments for bioconjugation and vascular immunotargeting. Bioconjugate Chemistry. PMID 29200285 DOI: 10.1021/Acs.Bioconjchem.7B00592 |
0.337 |
|
| 2017 |
Kiseleva R, Greineder CF, Villa CH, Hood ED, Shuvaev VV, Sun J, Chacko AM, Abraham V, DeLisser HM, Muzykantov VR. Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1. Plos One. 12: e0169537. PMID 28085903 DOI: 10.1371/Journal.Pone.0169537 |
0.301 |
|
| 2015 |
Matson ML, Villa CH, Ananta JS, Law JJ, Scheinberg DA, Wilson LJ. Encapsulation of α-Particle-Emitting 225Ac3+ Ions Within Carbon Nanotubes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 897-900. PMID 25931476 DOI: 10.2967/Jnumed.115.158311 |
0.559 |
|
| 2014 |
Villa JC, Chiu D, Brandes AH, Escorcia FE, Villa CH, Maguire WF, Hu CJ, de Stanchina E, Simon MC, Sisodia SS, Scheinberg DA, Li YM. Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancer. Cell Reports. 8: 1077-92. PMID 25131208 DOI: 10.1016/J.Celrep.2014.07.028 |
0.634 |
|
| 2013 |
Mulvey JJ, Villa CH, McDevitt MR, Escorcia FE, Casey E, Scheinberg DA. Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery Nature Nanotechnology. 8: 763-771. PMID 24077028 DOI: 10.1038/Nnano.2013.190 |
0.724 |
|
| 2011 |
Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, Korontsvit T, Zakhaleva V, Batt CA, Philips MR, Scheinberg DA. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. Acs Nano. 5: 5300-11. PMID 21682329 DOI: 10.1021/Nn200182X |
0.544 |
|
| 2011 |
Scheinberg DA, Villa CH, Escorcia F, Mcdevitt MR. Carbon Nanotubes Drug Delivery in Oncology: From Basic Research to Cancer Therapy. 2: 1163-1185. DOI: 10.1002/9783527634057.ch36 |
0.654 |
|
| 2010 |
Escorcia FE, Henke E, McDevitt MR, Villa CH, Smith-Jones P, Blasberg RG, Benezra R, Scheinberg DA. Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors. Cancer Research. 70: 9277-86. PMID 21045141 DOI: 10.1158/0008-5472.Can-10-2029 |
0.701 |
|
| 2010 |
Ruggiero A, Villa CH, Holland JP, Sprinkle SR, May C, Lewis JS, Scheinberg DA, McDevitt MR. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes. International Journal of Nanomedicine. 5: 783-802. PMID 21042424 DOI: 10.2147/Ijn.S13300 |
0.615 |
|
| 2010 |
Ruggiero A, Villa CH, Bander E, Rey DA, Bergkvist M, Batt CA, Manova-Todorova K, Deen WM, Scheinberg DA, McDevitt MR. Paradoxical glomerular filtration of carbon nanotubes. Proceedings of the National Academy of Sciences of the United States of America. 107: 12369-74. PMID 20566862 DOI: 10.1073/Pnas.0913667107 |
0.544 |
|
| 2010 |
Scheinberg DA, Villa CH, Escorcia FE, McDevitt MR. Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. Nature Reviews. Clinical Oncology. 7: 266-76. PMID 20351700 DOI: 10.1038/Nrclinonc.2010.38 |
0.689 |
|
| 2009 |
Escorcia FE, Henke E, McDevitt MR, Villa C, Smith-Jones P, Blasberg R, Benezra R, Scheinberg DA. Vascular Endothelial-Cadherin Targeted Alpha-Particle Mediated Vascular Killing and Remodeling Augments Subsequent Chemotherapeutic Efficacy. Blood. 114: 3054-3054. DOI: 10.1182/Blood.V114.22.3054.3054 |
0.7 |
|
| 2009 |
Mallikaratchy P, Ruggiero A, Maguire W, Piersanti K, Gardner J, Villa C, Escorcia F, Palomba ML, Heaney M, McDevitt MR, Scheinberg DA. Multivalent DNA Aptamer-Based Therapeutic Agents for Lymphoma and Leukemia. Blood. 114: 2711-2711. DOI: 10.1182/Blood.V114.22.2711.2711 |
0.685 |
|
| 2008 |
Villa CH, McDevitt MR, Escorcia FE, Rey DA, Bergkvist M, Batt CA, Scheinberg DA. Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes. Nano Letters. 8: 4221-8. PMID 19367842 DOI: 10.1021/Nl801878D |
0.711 |
|
| 2007 |
Escorcia FE, McDevitt MR, Villa CH, Scheinberg DA. Targeted nanomaterials for radiotherapy. Nanomedicine (London, England). 2: 805-15. PMID 18095847 DOI: 10.2217/17435889.2.6.805 |
0.722 |
|
| 2007 |
McDevitt MR, Chattopadhyay D, Jaggi JS, Finn RD, Zanzonico PB, Villa C, Rey D, Mendenhall J, Batt CA, Njardarson JT, Scheinberg DA. PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. Plos One. 2: e907. PMID 17878942 DOI: 10.1371/Journal.Pone.0000907 |
0.574 |
|
| Show low-probability matches. |